Inactive Instrument

Company Horizon Therapeutics Public Limited Company

Equities

HZNP

IE00BQPVQZ61

Pharmaceuticals

Business Summary

Horizon Therapeutics plc is an Ireland-based global biotechnology company. The Company is focused on the discovery, development and commercialization of medicines that address the critical needs of people impacted by rare, autoimmune and severe inflammatory diseases. The Company’s portfolio of medicines include ACTIMMUNE, BUPHENYL (sodium phenylbutyrate), PROCYSBI (cysteamine bitartrate), Prescription RAVICTI (glycerol phenylbutyrate), and other. ACTIMMUNE is part of a drug regimen used to treat Chronic Granulomatous Disease (CGD). BUPHENYL (sodium phenylbutyrate) is a tablet for oral administration and BUPHENYL (sodium phenylbutyrate) Powder for oral, nasogastric, or gastrostomy tube administration contains sodium phenylbutyrate. PROCYSBI (cysteamine bitartrate) delayed-release capsules and delayed-release oral granules is a prescription medicine used to treat nephropathic cystinosis in adults and children 1 year of age and older.

Number of employees: 2,190

Managers

Managers TitleAgeSince
Chief Executive Officer 57 08-05-31
Director of Finance/CFO 41 16-03-31
Chief Tech/Sci/R&D Officer 49 18-05-31
Chief Tech/Sci/R&D Officer 57 20-11-01
Chief Tech/Sci/R&D Officer 49 14-06-30
Chief Tech/Sci/R&D Officer 66 16-09-30
Chief Tech/Sci/R&D Officer 69 09-05-31
Sales & Marketing - 17-12-31
Comptroller/Controller/Auditor 45 15-01-31
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 57 08-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 229,378,934 226,691,767 ( 98.83 %) 384,366 ( 0.1676 %) 98.83 %

Company contact information

Horizon Therapeutics Plc

70 St. Stephen's Green

4, Dublin

+353 1 772 2100

http://www.horizontherapeutics.com
address Horizon Therapeutics Public Limited Company(HZNP)

Group companies

NameCategory and Sector
Horizon Pharma Treasury Ltd.
  1. Stock
  2. Equities
  3. Stock Horizon Therapeutics Public Limited Company - Nasdaq
  4. Company Horizon Therapeutics Public Limited Company